A sharp sell-off in gold and silver, alongside falling oil prices, has sparked volatility across global markets at the start of a week packed with major earnings and central bank decisions.
After a historic surge, gold prices have experienced their steepest drop in decades. Yet, analysts point to enduring geopolitical tensions and monetary policy shifts as reasons why the metal's long-term appeal remains intact.
Amidst a mixed economic backdrop, we spotlight three U.S. tech companies—Rumble, Daktronics, and Sandisk—whose strategic initiatives and robust growth projections set them apart for investors looking beyond near-term turbulence.
Amid a choppy market landscape in early 2026, value investors are scanning for opportunities. We analyze three companies—Viavi Solutions, Kontoor Brands, and Robert Half—whose current share prices appear significantly disconnected from their estimated intrinsic worth based on cash flow projections.
While major indices capture headlines, a deeper look reveals potential in select small-cap banks. We analyze three financial institutions with strong fundamentals, strategic moves, and valuations that may offer compelling opportunities for discerning investors.
ZJK Industrial Co., Ltd. (NASDAQ:ZJK) has seen its shares tumble 25% in three months. We analyze whether its mixed financial fundamentals, including a middling Return on Equity and stagnant earnings, justify the market's pessimistic stance.
The Chinese online recruitment platform Kanzhun Ltd. is showing marked improvement in its capital returns, a key indicator of operational efficiency and potential long-term value creation for investors.
In Zimbabwe, where formal employment is scarce and medical costs are prohibitive, a stark financial choice is being made: affordable funeral policies are vastly outpacing health insurance, reflecting a cultural prioritization of dignified burials over accessible healthcare.
The aunt and cousin of Mexico's Secretary of Public Education, Mario Delgado, were fatally shot in their Colima home. Authorities later killed three suspects in a confrontation, highlighting the persistent violence plaguing the region.
The all-stock deal creates a top-tier independent producer focused on the Permian Basin, with Beth McDonald at the helm aiming to unlock significant synergies and shareholder returns.
Precious metals extended their sharp decline following President Trump's nomination for the next Federal Reserve chair, a move markets interpret as locking in higher interest rates and boosting the U.S. dollar's appeal.
Private equity firm Exponent has halted the auction of UK accounting group Xeinadin after potential buyers refused to meet its £1bn valuation, signaling potential headwinds for deal-making in the professional services sector.
Millions rely on Medicare, yet common misunderstandings about its coverage rules and costs can lead to significant financial shocks in retirement. We clarify three critical areas where assumptions often prove wrong.
Essar Oil and Gas Exploration & Production (EOGEPL) is injecting $100 million into its flagship Raniganj East CBM block in West Bengal, aiming to scale up domestic natural gas production and explore shale potential in a bid to reduce India's import reliance.
The business services sector has mirrored the broader market's gains, but a wave of AI-driven disruption is separating the resilient from the vulnerable. We analyze one stock facing headwinds and two with the fundamentals to potentially thrive.
Despite a strong three-year run, shares of Ollie's Bargain Outlet (OLLI) dipped this week, prompting investors to weigh its solid earnings growth against recent market performance.
Oracle announces plans to raise up to $50 billion in 2026 through debt and equity to massively expand its cloud data centers, aiming to meet surging demand from AI leaders like Nvidia, OpenAI, and xAI.
Despite posting impressive revenue and subscriber growth in 2025, Netflix faces a critical headwind: its share of viewer engagement is growing at a fraction of the overall streaming market's pace, signaling intensified competition for attention.
While Vidhance (FRA:8W50) continues to operate at a loss, its current cash reserves and manageable burn rate suggest the company has time to execute its growth strategy. However, a recent dip in revenue adds a note of caution for investors.
While investors chase AI and big tech, a niche biotech firm focused on rare genetic obesity disorders has quietly delivered staggering returns, with Wall Street seeing further 40% upside. Rhythm Pharmaceuticals' targeted approach and upcoming catalysts have analysts bullish, despite its relative anonymity.
